Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Comment by Bowerpoweron Nov 17, 2016 11:21pm
145 Views
Post# 25478986

RE:RE:RE:RE:RE:RE:RE:RE:Breaking 20

RE:RE:RE:RE:RE:RE:RE:RE:Breaking 20I got an email from NF about this, and this is what they told me.

Share Distribution Record Date

The board of directors of New Age Farm have set the share distribution record date of the Plan of Arrangement at close of business on November 30, 2016 (the “Share Distribution Record Date”).  Shareholders as of the Share Distribution Record Date will be entitled to receive the New Shares and the NHS Shares.  Each shareholder of record on November 30, 2016 will participate in the Arrangement on a pro–rata basis and, upon completion of the Arrangement, will continue to hold substantially the same pro–rata interest they held in the Company prior to completion of the Arrangement.  The New Shares will be identical in every respect to the shareholders’ current New Age Farm shares; in addition, each New Age Farm shareholder will receive from NHS the number of common shares equal to the issued and outstanding common shares of New Age Farm held by the shareholder as of the Share Distribution Record Date, divided by an exchange ratio.

 

The shareholders of NHS have approved the Arrangement;

     NHS will transfer the NHS transferred liabilities as described in the Arrangement Agreement, subject to final adjustments, to New Age Farm (the "NHS Transferred Liabilities");

     NHS will issue that number of common shares of NHS to New Age Farm that will equal the value of the NHS Transferred Liabilities, at a deemed price of not less than $0.03 per NHS shares and not more than $0.10 per NHS share.

     NHS will effect a share consolidation of the NHS shares on the basis of up to 1 new NHS share for each 5 previously held NHS shares (the "Post-consolidation NHS Shares");

 

     New Age Farm shares will remain unchanged; only the NHS shares will be subject to consolidation;

Bullboard Posts